Ozempic and Pancreatitis: How GLP-1 Drugs May Damage the Pancreas
Pancreatitis — inflammation of the pancreas — is a serious and potentially life-threatening condition. Multiple studies and FDA post-market safety reviews have explored the association between GLP-1 drugs like Ozempic and an elevated risk of pancreatitis. Patients who developed acute or chronic pancreatitis after using Ozempic, Wegovy, or Mounjaro have filed lawsuits alleging the manufacturers failed to adequately warn of this risk.
In This Article
What Is Pancreatitis
The pancreas produces digestive enzymes and insulin. Pancreatitis occurs when these digestive enzymes activate inside the pancreas itself, causing severe inflammation and self-digestion of pancreatic tissue. Acute pancreatitis causes intense abdominal pain, nausea, and vomiting and typically requires hospitalization. Chronic pancreatitis can develop after repeated episodes and leads to permanent damage, including pancreatic insufficiency, diabetes, and increased risk of pancreatic cancer.
How GLP-1 Drugs May Cause Pancreatitis
GLP-1 receptors are expressed in pancreatic cells, and GLP-1 agonists stimulate these receptors as part of their glucose-regulating mechanism. Scientists have hypothesized that this stimulation can cause abnormal activation of pancreatic enzymes or pancreatic duct obstruction. Early clinical trials of GLP-1 drugs showed higher rates of pancreatitis compared to placebo. The FDA required GLP-1 manufacturers to monitor and report pancreatitis cases, and the drug labels carry pancreatitis warnings — but lawsuits allege the warnings were inadequate given the known risk.
Developed pancreatitis after using Ozempic or Mounjaro?
Find out if you may qualify — free case review.
Check Eligibility arrow_forwardRecognizing Ozempic-Related Pancreatitis
Pancreatitis symptoms typically begin with severe upper abdominal pain that may radiate to the back, accompanied by nausea, vomiting, and fever. If you experienced these symptoms while using a GLP-1 drug and were hospitalized, blood tests likely showed elevated lipase and amylase — enzymes that confirm pancreatic inflammation. The onset of symptoms typically occurs within the first few months of starting the drug or after a dose increase. Stop the medication immediately and seek emergency care if you experience these symptoms.
Filing an Ozempic Pancreatitis Claim
To file a pancreatitis-related Ozempic lawsuit, you need documented use of Ozempic, Wegovy, Mounjaro, or another GLP-1 drug and a confirmed pancreatitis diagnosis supported by elevated enzyme levels, imaging, or hospitalization records. Cases are strongest when pancreatitis developed after starting a GLP-1 drug with no significant alternative causes such as gallstones or heavy alcohol use. An attorney will review your medical records to assess causation and strength of your claim.
Frequently Asked Questions
If I had gallstones before taking Ozempic, can I still file a pancreatitis claim?expand_more
Gallstones are a common alternative cause of pancreatitis, which complicates causation arguments. However, if your treating physicians attributed your pancreatitis to Ozempic, or if you had no active gallstone complications before starting Ozempic, you may still have a viable claim. An attorney can assess the medical records.
How much compensation can a pancreatitis Ozempic victim receive?expand_more
It is too early in the litigation for reliable settlement ranges, as major Ozempic personal injury verdicts have not yet emerged. Compensation will depend on severity — hospitalization and temporary pancreatitis versus chronic pancreatitis with permanent damage. Cases involving pancreatic cancer following chronic pancreatitis may command the highest damages.
Do I need to have stopped using Ozempic to file a claim?expand_more
No. You can file a lawsuit while still on the medication. However, if your pancreatitis was caused by Ozempic, your physician may recommend stopping the drug. Follow your doctor's medical advice about continuing or discontinuing — legal strategy should not override medical judgment.
SuperLawsuits Editorial Team
Reviewed by licensed attorneys in our network